Coronavirus quick test
OnGite COVID-19 Rapid Test (Coronavirus) IgG / IgM is a horizontal enzyme-linked immunosorbent chromatography test to detect IgG and IgM antibodies against SARS-CoV-2 in human serum, plasma or whole blood. It is intended for use by medical professionals as an aid in the diagnosis of SARS-CoV-2 coronavirus infection, which causes COVID-19 disease (coronavirus). Any interpretation or use of this preliminary test result is also based on other clinical data, as well as on the professional judgment of medical professionals. Alternative test methods should be considered to confirm the test results obtained by this device.
EXPLANATION OF THE TEST QUICK TEST CORONAVIRUS
SARS-CoV-2 belongs to a wide family of coronaviruses that can cause diseases ranging from colds to more serious diseases. SARS-CoV-2 infections cause COVID-19 disease. Infected patients have a wide range of clinical symptoms, from mild to no symptoms, to fever, fatigue and dry cough, which can lead to serious illness and death. Most patients recover without special treatment. About 1 out of every 6 patients receiving COVID-19 (coronavirus) was seriously ill and had breathing problems. Older people and those with serious health problems, such as high blood pressure, heart problems, or diabetes, are more likely to get sick. Human-to-human transmission of the virus has been confirmed and occurs primarily through respiratory drops from coughing and sneezing within about 6 feet (1.8 m). Viral RNA has also been detected in stool samples from patients. It is possible that the virus may be contagious even during the incubation period, but this has not been proven. Currently, the laboratory method for detecting COVID-19 is RT-PCR. However, this method requires sophisticated equipment and highly qualified laboratory assistants. Moreover, viral load rapidly decreases from 9 or 10 days after the onset of symptoms. During the acute phase of infection, the IgM titer of SARS-CoV rapidly increases and reaches a peak approximately 2–3 weeks after infection. SARS-CoV-specific IgG antibodies appear shortly after IgM and persist for 6 months. SARS-CoV-specific antibodies are useful markers for diagnosis and epidemiological screening. OnGite COVID-19 IgG / IgM rapid test detects antibodies against SARS-CoV-2 IgG and IgM in human serum, plasma or whole blood. The test can be performed within 15 minutes by minimally qualified personnel without the use of bulky laboratory equipment.
TEST PRINCIPLE QUICK TEST CORONAVIRUS
OnGite COVID-19 IgG / IgM Rapid Test is a horizontal chromatographic immunoassay. The test strip in the cassette consists of: 1) a colored conjugate pad containing recombinant SARS-CoV-2 antigens conjugated to colloidal gold (SARS-CoV-2 Ag conjugates) and a control antibody conjugated to colloidal gold, 2) nitrocellulose membrane strip containing two test lines (lines G and M) and a control line (line C). Line G is pre-coated with antibodies to detect anti-SARS-CoV-2 IgG, line M is pre-coated with antibodies to detect anti-SARS-CoV-2 IgM, and line C is pre-coated with an antibody control line. When a sufficient volume of the sample is dosed into the sample well of the test cassette, the sample migrates by capillaries along the strip of the cassette. Anti-SARS-CoV-2 IgG, if present in the sample, will bind to SARS-CoV-2 Ag conjugates. The immunocomplexes are then carried away by pre-coated anti-human IgG, forming a colored G line, indicating a positive SARS-CoV-2 IgG test result, indicating a secondary or past infection with the SARS-CoV-2 virus. Anti-SARS-CoV2 IgM, if present in the sample, will bind to SARS-CoV2 Ag conjugates. The immunocomplexes are then carried away by a pre-coated anti-human IgM, forming a stained M line, which indicates a positive anti-SARS-CoV-2 IgM test result and which provides for an acute SARS-CoV-2 infection, either primary or secondary. A positive IgM and IgG result provides for late primary or early secondary acute infection. The absence of any of the test lines (G or M) provides a negative result. Each test contains an internal control (line C), which should have a color line of control antibodies, regardless of color development on any of the test lines. If line C does not develop, the test result is invalid and the sample must be retested with another device.
MATERIALS AND REAGENTS INCLUDED IN THE COMPOSITION OF THE SET OF QUICK TEST CORONAVIRUS
Individually sealed foil bags containing: b. One product cassette c. One Desiccant Plastic Pipette Detection Buffer (REF SB-R01
- Brands CTK Biotech, США
- Product Code: 1 уп 30 шт
- Availability: In Stock